The Biden-Harris administration announced it has successfully negotiated significant reductions in prescription drug prices through Medicare, easing the financial burden on millions of seniors.
The Inflation Reduction Act of 2022 has empowered Medicare to negotiate prices with drug manufacturers, predicted to save taxpayers $6 billion by 2026.
Seniors often faced hard choices between essential medications and basic needs due to high drug prices; now this initiative addresses that injustice.
This is a historic moment for healthcare reform, as Medicare can now secure better deals for the most costly medications for American seniors.
[
Collection
]
[
|
...
]